Company profile for SQZ Biotechnologies

SQZ Biotechnologies

NEW Drugs in Dev.: 5

Evonik

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

pharmacompass-1-m-2026-01-12

Contact Supplier

End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

Contact Supplier

Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

Contact Supplier

pharmacompass-2-m-2025-11-03

Contact Supplier

VISIT THE VIRTUAL BOOTH
Review portfolio & marketing content
CONTACT DETAILS
Google Map, LinkedIn, Emails...

DIGITAL CONTENT

42 News #PharmaBuzz

media
42 News #PharmaBuzz

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At SQZ we believe that cell therapies can revolutionize the way we treat diseases. The SQZ cell therapy platform can be the foundation of a new generation of therapeutics. By enabling engineering of almost any function into any cell type, the SQZ platform overcomes fundamental barriers in the field and enabling creation of diversity of previously infeasible cell therapies. Our current focus is on creating high-impact therapies...

At SQZ we believe that cell therapies can revolutionize the way we treat diseases. The SQZ cell therapy platform can be the foundation of a new generation of therapeutics. By enabling engineering of almost any function into any cell type, the SQZ platform overcomes fundamental barriers in the field and enabling creation of diversity of previously infeasible cell therapies. Our current focus is on creating high-impact therapies for patients in the fields of oncology and auto-immunity. Ultimately, SQZ has the potential to create therapies addressing a broad range of diseases.

Tides AsiaTides Asia

Not Confirmed

Not Confirmed

24-26 February, 2026

Tokyo, Japan
BIO Partnering at JPMBIO Partnering at JPM

Not Confirmed

Not Confirmed

12-15 January, 2026

San Francisco Marriott Marquis, California
Biotech ShowcaseBiotech Showcase

Not Confirmed

Not Confirmed

12-14 January, 2026

San Diego, California, U.S.A

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown

United_States_of_America Flag

Country

Country

U.S.A

Address

Address

134 Coolidge Avenue Watertown, MA 02472

Telephone

Telephone

617) 758-8672

Email

enquiries@pharmacompass.com

Client Website

Website

https://sqzbiotech.com/

Linkedin

https://www.linkedin.com/company/sqz-biotechnologies/

youtube

YouTube

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

SQZ opts for liquidation, $11.8M asset fire sale to Stemcell

01 Mar 2024

// James Waldron FIERCE BIOTECH

STEMCELL Technologies Announces Successful Asset Purchase Agreement with SQZ Bio

29 Feb 2024

// BUSINESSWIRE

Ahead of shareholder vote on SQZ asset sale and liquidation

14 Feb 2024

// Amber Tong ENDPTS

SQZ founder Armon Sharei opens Portal to cell engineering

12 Dec 2023

// Gabrielle Masson FIERCE BIOTECH

SQZ lays off 80% of staff, Regenxbio cuts 15%

09 Nov 2023

// James Waldron FIERCE BIOTECH

SQZ Biotechnologies Reports Third Quarter 2023 Financial Results

08 Nov 2023

// BUSINESSWIRE

Drugs in Development

Full Screen View

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Market Place

Home

Menu

Post Enquiry

Market Place

Search